Physician profile
Scott M Munro
NPI 1912900622
$1,699.60
in general payments reported to CMS, 2019-2025
20 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $37.70 · 2022: $224 · 2023: $549 · 2024: $378 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $331.37 | 2022-2024 | Aveir, Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.18 | 2019-2024 | Jardiance |
| Baxter Healthcare | $151.06 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $131.84 | 2022-2025 | |
| Edwards Lifesciences Corporation | $129.60 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $123.88 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $90.35 | 2019-2020 | |
| Amgen INC. | $77.92 | 2019-2025 | Repatha |
| Pfizer INC. | $73.45 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $62.01 | 2023-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.39 | 2019-2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $49.11 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $40.14 | 2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $38.02 | 2019 | |
| Scpharmaceuticals INC. | $19.34 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $18.75 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $16.29 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.06 | 2023 | Evkeeza |
| Altathera Pharmaceuticals LLC | $14.69 | 2025 | Sotalol Hydrochloride |
| Philips North America LLC | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Munro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.